TARDBP and amyotrophic lateral sclerosis: However, “comorbid pathology” is clearly distinguished from such “concomitant disorders” by the limited extension of TDP-43 pathology, lack of clinical findings diagnostic of ALS/FTLD-TDP, and a much higher prevalence than that expected for the incidental concurrence of two neurodegenerative disorders.